<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>General Practice (Scholarly Articles)</title>
<link>http://hdl.handle.net/10379/1214</link>
<description/>
<pubDate>Sun, 29 Oct 2017 23:45:03 GMT</pubDate>
<dc:date>2017-10-29T23:45:03Z</dc:date>
<item>
<title>The efficacy of mindfulness-based interventions in primary care: a meta-analytic review</title>
<link>http://hdl.handle.net/10379/6656</link>
<description>The efficacy of mindfulness-based interventions in primary care: a meta-analytic review
Demarzo, Marcelo M.P.; Montero-Marin, Jesús; Cuijpers, Pim; Zabaleta-del-Olmo, Edurne; Mahtani, Kamal R.; Vellinga, Akke; Vicens, Caterina; López-del-Hoyo, Yolanda; García-Campayo, Javier
PURPOSE Positive effects have been reported after mindfulness-based interventions (MBIs) in diverse clinical and nonclinical populations. Primary care is a key health care setting for addressing common chronic conditions, and an effective MBI designed for this setting could benefit countless people worldwide. Meta-analyses of MBIs have become popular, but little is known about their efficacy in primary care. Our aim was to investigate the application and efficacy of MBIs that address primary care patients.METHODS We performed a meta-analytic review of randomized controlled trials addressing the effect of MBIs in adult patients recruited from primary care settings. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and Cochrane guidelines were followed. Effect sizes were calculated with the Hedges g in random effects models.RESULTS The meta-analyses were based on 6 trials having a total of 553 patients. The overall effect size of MBI compared with a control condition for improving general health was moderate (g = 0.48; P = .002), with moderate heterogeneity (I-2 = 59; P . 05).CONCLUSIONS Although the number of randomized controlled trials applying MBIs in primary care is still limited, our results suggest that these interventions are promising for the mental health and quality of life of primary care patients. We discuss innovative approaches for implementing MBIs, such as complex intervention and stepped care.
</description>
<pubDate>Thu, 16 Jul 2015 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10379/6656</guid>
<dc:date>2015-07-16T00:00:00Z</dc:date>
</item>
<item>
<title>Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial</title>
<link>http://hdl.handle.net/10379/6611</link>
<description>Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial
Vellinga, Akke; Galvin, Sandra; Duane, Sinead; Callan, Aoife; Bennett, Kathleen; Cormican, Martin; Domegan, Christine; Murphy, Andrew W.
Background: Overuse of antimicrobial therapy in the community adds to the global spread of antimicrobial resistance, which is jeopardizing the treatment of common infections.Methods: We designed a cluster randomized complex intervention to improve antimicrobial prescribing for urinary tract infection in Irish general practice. During a 3-month baseline period, all practices received a workshop to promote consultation coding for urinary tract infections. Practices in intervention arms A and B received a second workshop with information on antimicrobial prescribing guidelines and a practice audit report (baseline data). Practices in intervention arm B received additional evidence on delayed prescribing of antimicrobials for suspected urinary tract infection. A reminder integrated into the patient management software suggested first-line treatment and, for practices in arm B, delayed prescribing. Over the 6-month intervention, practices in arms A and B received monthly audit reports of antimicrobial prescribing.Results: The proportion of antimicrobial prescribing according to guidelines for urinary tract infection increased in arms A and B relative to control (adjusted overall odds ratio [OR] 2.3, 95% confidence interval [CI] 1.7 to 3.2; arm A adjusted OR 2.7, 95% CI 1.8 to 4.1; arm B adjusted OR 2.0, 95% CI 1.3 to 3.0). An unintended increase in antimicrobial prescribing was observed in the intervention arms relative to control (arm A adjusted OR 2.2, 95% CI 1.2 to 4.0; arm B adjusted OR 1.4, 95% CI 0.9 to 2.1). Improvements in guideline-based prescribing were sustained at 5 months after the intervention.Interpretation: A complex intervention, including audit reports and reminders, improved the quality of prescribing for urinary tract infection in Irish general practice.
</description>
<pubDate>Mon, 16 Nov 2015 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10379/6611</guid>
<dc:date>2015-11-16T00:00:00Z</dc:date>
</item>
<item>
<title>The cost effectiveness of the SIMPle intervention to improve antimicrobial prescribing for urinary tract infection in primary care</title>
<link>http://hdl.handle.net/10379/6610</link>
<description>The cost effectiveness of the SIMPle intervention to improve antimicrobial prescribing for urinary tract infection in primary care
Gillespie, Paddy; Callan, Aoife; O'Shea, Eamon; Duane, Sinead; Murphy, Andrew W.; Domegan, Christine; Galvin, Sandra; Vellinga, Akke
Abstract&#13;
Background&#13;
Antimicrobial resistance is a major public health issue. This study examines the cost effectiveness of the SIMPle (Supporting the Improvement and Management of Prescribing for Urinary Tract Infections (UTI)) intervention to improve antimicrobial prescribing in primary care in Ireland.&#13;
Methods&#13;
An economic evaluation was conducted alongside a cluster randomized controlled trial of 30 general practices and 2560 patients with a diagnosis of UTI. Practices were randomized to the usual practice control or the SIMPle intervention (arm A or B). Data at 6 months follow-up were used to estimate incremental costs, incremental effectiveness in terms of first-line antimicrobial prescribing for UTI and cost effectiveness acceptability curves.&#13;
Results&#13;
The SIMPle intervention was, on average, more costly and more effective than the control. The probability of intervention arm A being cost effective was 0.280, 0.995 and 1.000 at threshold values of €50, €150 and €250 per percentage point increase in first-line antimicrobial prescribing respectively. The equivalent probabilities for intervention arm B were 0.121, 0.863 and 0.985, respectively.&#13;
Conclusions&#13;
The cost effectiveness of the SIMPle intervention depends on the value placed on improving antimicrobial prescribing. Future studies should examine the wider and longer term costs and outcomes of improving antimicrobial prescribing.
</description>
<pubDate>Tue, 27 Sep 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10379/6610</guid>
<dc:date>2016-09-27T00:00:00Z</dc:date>
</item>
<item>
<title>Reconsultation and antimicrobial treatment of urinary tract infection in male and female patients in general practice</title>
<link>http://hdl.handle.net/10379/6609</link>
<description>Reconsultation and antimicrobial treatment of urinary tract infection in male and female patients in general practice
Tandan, Meera; Duane, Sinead; Cormican, Martin; Murphy, Andrew W.; Vellinga, Akke
Current antimicrobial prescribing guidelines indicate that male and female patients with urinary tract infections (UTIs) should be treated with same antimicrobials but for different durations. The aim of this study was to explore the differences in reconsultations and antimicrobial prescribing for UTI for both males and females. A total of 2557 adult suspected UTI patients participating in the Supporting the Improvement and Management of Prescribing for urinary tract infection (SIMPle) study from 30 general practices were analyzed. An antimicrobial was prescribed significantly more often to females (77%) than males (63%). Nitrofurantoin was prescribed more often for females and less often for males (58% vs. 41%), while fluoroquinolones were more often prescribed for males (11% vs. 3%). Overall, reconsultation was 1.4 times higher in females, and if the antimicrobial prescribed was not the recommended first-line (nitrofurantoin), reconsultation after empirical prescribing was significantly higher. However, the reconsultation was similar for males and females if the antimicrobial prescribed was first-line. When a urine culture was obtained, a positive culture was the most important predictor of reconsultation (Odds ratio 1.8 (95% CI 1.3-2.5)). This suggests, when prescribing empirically, that male and female UTI patients should initially be treated with first-line antimicrobials (nitrofurantoin) with different durations (50-100 mg four times daily for three days in females and seven days for males). However, the consideration of a culture test before prescribing antimicrobials may improve outcomes.
</description>
<pubDate>Thu, 15 Sep 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10379/6609</guid>
<dc:date>2016-09-15T00:00:00Z</dc:date>
</item>
</channel>
</rss>
